Literature DB >> 6365036

Infection of gnotobiotic calves with a bovine and human isolate of respiratory syncytial virus. Modification of the response by dexamethasone.

L H Thomas, E J Stott, A P Collins, S Crouch, J Jebbett.   

Abstract

A bovine and a human strain of RSV both adapted to bovine cell culture, have been inoculated separately into 13 and 7 gnotobiotic calves respectively by 3 different methods. Both strains infected calves and showed similar growth patterns. Virus was recovered from the nasopharynx between one and 11 days with peak titres between 3 and 8 days following inoculation. With the exception of 4 calves treated with dexamethasone no clinical signs and only minimal macroscopic lesions of the lung were induced, which histologically comprised a mononuclear infiltration of alveolar walls and of the peribronchiolar tissue. The serological response to both strains was similar. Antibody was detected by virus neutralisation or single radial haemolysis from 12 days after inoculation. Specific anti-RSV IgM was detected from 10 days and IgG from 16 days after inoculation. Treatment with dexamethasone (0.5 mgm/Kg daily for 10 days) enhanced lung lesions produced by the bovine strain, prolonged the period of virus shedding and increased peak titres. The specific IgM response was suppressed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365036     DOI: 10.1007/bf01314304

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Comparison of three methods for sampling the bovine upper respiratory tract for viruses.

Authors:  L H Thomas; E J Stott
Journal:  Res Vet Sci       Date:  1975-03       Impact factor: 2.534

2.  Experimental infection of calves with respiratory syncytial virus.

Authors:  J W Jacobs; N Edington
Journal:  Res Vet Sci       Date:  1975-05       Impact factor: 2.534

3.  Experimentally induced respiratory syncytial viral infection in calves.

Authors:  S B Mohanty; A L Ingling; M G Lillie
Journal:  Am J Vet Res       Date:  1975-04       Impact factor: 1.156

4.  Bovine respiratory syncytial virus. Studies on an outbreak in Japan, 1968-1969.

Authors:  Y Inaba; Y Tanaka; K Sato; T Omori; M Matumoto
Journal:  Jpn J Microbiol       Date:  1972-09

5.  Reactivation of a bovine herpesvirus after corticosteroid treatment.

Authors:  B E Sheffy; D H Davies
Journal:  Proc Soc Exp Biol Med       Date:  1972-07

6.  A comparison of the polypeptides of human and bovine respiratory syncytial viruses and murine pneumonia virus.

Authors:  P Cash; W H Wunner; C R Pringle
Journal:  Virology       Date:  1977-10-15       Impact factor: 3.616

7.  Experimental pneumonia in gnotobiotic calves produced by respiratory syncytial virus.

Authors:  L H Thomas; E J Slott; A P Collins; J Jebbett
Journal:  Br J Exp Pathol       Date:  1984-02

8.  Respiratory syncytial virus pneumonia in young calves: clinical and pathologic findings.

Authors:  D G Bryson; M S McNulty; E F Logan; P F Cush
Journal:  Am J Vet Res       Date:  1983-09       Impact factor: 1.156

9.  Use of corticosteroids to isolate IBR virus from cattle in Cyprus after respiratory disease and ataxia.

Authors:  E P Gibbs; G Pitzolis; M J Lawman
Journal:  Vet Rec       Date:  1975-05-24       Impact factor: 2.695

10.  Diagnosis of respiratory syncytial virus infection in the bovine respiratory tract by immunofluorescence.

Authors:  L H Thomas; E J Stott
Journal:  Vet Rec       Date:  1981-05-16       Impact factor: 2.695

View more
  11 in total

Review 1.  Animal models of human respiratory syncytial virus disease.

Authors:  Reinout A Bem; Joseph B Domachowske; Helene F Rosenberg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

Review 2.  Respiratory syncytial virus. Brief review.

Authors:  E J Stott; G Taylor
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 3.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

4.  Evaluation of a nested reverse transcription-PCR assay based on the nucleoprotein gene for diagnosis of spontaneous and experimental bovine respiratory syncytial virus infections.

Authors:  J F Valarcher; H Bourhy; J Gelfi; F Schelcher
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 5.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

6.  Bovine respiratory syncytial virus protects cotton rats against human respiratory syncytial virus infection.

Authors:  F M Piazza; S A Johnson; M E Darnell; D D Porter; V G Hemming; G A Prince
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

7.  An experimental study of a concurrent primary infection with bovine respiratory syncytial virus (BRSV) and bovine viral diarrhoea virus (BVDV) in calves.

Authors:  M Elvander; C Baule; M Persson; L Egyed; A Ballagi-Pordány; S Belák; S Alenius
Journal:  Acta Vet Scand       Date:  1998       Impact factor: 1.695

8.  The effect of dexamethasone-induced immunosuppression on the development of faecal antibody and recovery from and resistance to rotavirus infection.

Authors:  G Oldham; J C Bridger
Journal:  Vet Immunol Immunopathol       Date:  1992-04       Impact factor: 2.046

Review 9.  Calf pneumonia.

Authors:  D G Bryson
Journal:  Vet Clin North Am Food Anim Pract       Date:  1985-07       Impact factor: 3.357

10.  Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.

Authors:  Krister Blodörn; Sara Hägglund; Jenna Fix; Catherine Dubuquoy; Boby Makabi-Panzu; Michelle Thom; Per Karlsson; Jean-Louis Roque; Erika Karlstam; John Pringle; Jean-François Eléouët; Sabine Riffault; Geraldine Taylor; Jean François Valarcher
Journal:  PLoS One       Date:  2014-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.